B cells derived from MS patients secrete high levels of pro-inflammatory cytokines (TNF-α, Lymphotoxin-a, IL-6 and GM-CSF) (48, 49), but have a diminished capability to produce IL-10 (48, 50) (Figure 2). This evidence concerns the gene CSF2 and myeloid sarcoma.